Stephanie has extensive R&D experience in the biotechnology/pharmaceutical industry at several stages of drug development, from preclinical discovery and nonclinical IND-enabling through clinical assay development and product characterization. Her expertise includes nucleic-based vaccines and immunotherapeutics, small molecules, and biologics, all for a variety of disease indications including autoimmunity, infectious diseases, and cancer. She is currently VP of R&D Biology at TriLink. Prior, leading a team developing innovations in the mRNA space. Prior to joining TriLink, Stephanie spent over 15 years in R&D in different San Diego/Southern California area companies, both small VC-funded startups mid-sized biotech. She received her B.S. in Molecular Biology from UC San Diego and her PhD in Molecular Biology, Genetics and Biochemistry from UC Irvine.